A Review on Emerging Techniques for Diagnosis of Colorectal Cancer

References

• Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335.e15–349.e15. doi:10.1053/j.gastro.2020.02.068.
   Web of Science ®Google Scholar
• Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, et al. Colon cancer. Crit Rev Oncol Hematol. 2010;74(2):106–133. doi:10.1016/j.critrevonc.2010.01.010.
   PubMed Web of Science ®Google Scholar
• Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10):101174. doi:10.1016/j.tranon.2021.101174.
   PubMed Web of Science ®Google Scholar
• Vieira AR, Abar L, Chan DS, Vingeliene S, Polemiti E, Stevens C, et al. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR continuous update project. Ann Oncol. 2017;28(8):1788–1802. doi:10.1093/annonc/mdx171.
   PubMed Web of Science ®Google Scholar
• André T, De Gramont A, Vernerey D, Chibaudel B, Bonnetain F, Tijeras-Raballand A, et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC Study. J Clin Oncol. 2015;33(35):4176–4187. doi:10.1200/JCO.2015.63.4238.
   PubMed Web of Science ®Google Scholar
• Kim CW, Baek JH, Choi GS, Yu CS, Kang SB, Park WC, et al. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: study protocol for a randomized controlled trial. Trials. 2016;17(1):34. doi:10.1186/s13063-016-1164-0.
   PubMedGoogle Scholar
• Pinson H, Cosyns S, Ceelen WP. The impact of surgical resection of the primary tumor on the development of synchronous colorectal liver metastasis: a systematic review. Acta Chir Belg. 2018;118(4):203–211. doi:10.1080/00015458.2018.1446602.
   PubMed Web of Science ®Google Scholar
• Tepus M, Yau TO. Non-invasive colorectal cancer screening: an overview. Gastrointest Tumors. 2020;7(3):62–73. doi:10.1159/000507701.
   PubMed Web of Science ®Google Scholar
• Wen Y, Zhao S, Holmqvist A, Hahn-Stromberg V, Adell G, Holmlund B, et al. Predictive Role of Biopsy Based Biomarkers for Radiotherapy Treatment in Rectal Cancer. J Pers Med. 2020;10(4):168. doi:10.3390/jpm10040168.
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ. Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: the importance of cancer prevention in addition to cancer detection. Abdom Radiol. 2016;41(8):1441–1444. doi:10.1007/s00261-016-0798-4.
   PubMed Web of Science ®Google Scholar
• Ding Y, Li W, Wang K, Xu C, Hao M, Ding L. Perspectives of the application of liquid biopsy in colorectal cancer. Biomed Res Int. 2020;2020:6843180–13. doi:10.1155/2020/6843180.
   PubMed Web of Science ®Google Scholar
• Mazouji O, Ouhajjou A, Incitti R, Mansour H. Updates on clinical use of liquid biopsy in colorectal cancer screening, diagnosis, follow-up, and treatment guidance. Front Cell Dev Biol. 2021;9:660924. doi:10.3389/fcell.2021.660924.
   PubMed Web of Science ®Google Scholar
• Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021;116(3):458–479. doi:10.14309/ajg.0000000000001122.
   PubMed Web of Science ®Google Scholar
• Patel SG, May FP, Anderson JC, Burke CA, Dominitz JA, Gross SA, et al. Updates on age to start and stop colorectal cancer screening: recommendations from the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2022;162(1):285–299. doi:10.1053/j.gastro.2021.10.007.
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016. 315(23):2564–2575. doi:10.1001/jama.2016.5989.
   PubMed Web of Science ®Google Scholar
• Hatamian S, Hadavandsiri F, Momenimovahed Z, Salehiniya H. Barriers and facilitators of colorectal cancer screening in Asia. Ecancermedicalscience. 2021;15:1285. doi:10.3332/ecancer.2021.1285.
   PubMed Web of Science ®Google Scholar
• Honoré N, Galot R, van Marcke C, Limaye N, Machiels JP. liquid biopsy to detect minimal residual disease: Methodology and impact. Cancers. 2021;13(21):5364. doi:10.3390/cancers13215364.
   PubMed Web of Science ®Google Scholar
• Ebner DW, Kisiel JB. Stool-based tests for colorectal cancer screening: performance benchmarks lead to high expected efficacy. Curr Gastroenterol Rep. 2020;22(7):32. doi:10.1007/s11894-020-00770-6.
   PubMedGoogle Scholar
• Katsoula A, Paschos P, Haidich A-B, Tsapas A, Giouleme O. Diagnostic accuracy of fecal immunochemical test in patients at increased risk for colorectal cancer: a meta-analysis. JAMA Intern Med. 2017;177(8):1110–1118. doi:10.1001/jamainternmed.2017.2309.
   PubMed Web of Science ®Google Scholar
• Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171–181. doi:10.7326/M13-1484.
   PubMed Web of Science ®Google Scholar
• Elsafi SH, Alqahtani NI, Zakary NY, Al Zahrani EM. The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings. Clin Exp Gastroenterol. 2015; 8:279–284. doi:10.2147/CEG.S86419.
   PubMed Web of Science ®Google Scholar
• Grobbee EJ, Wisse PH, Schreuders EH, van Roon A, van Dam L, Zauber AG, et al. Guaiac‐based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average‐risk individuals. Cochrane Database Syst Rev. 2022; 6(6):CD009276. doi:10.1002/14651858.CD009276.pub2.
   PubMedGoogle Scholar
• Potter NT, Hurban P, White MN, Whitlock KD, Lofton-Day CE, Tetzner R, et al. Validation of a real-time PCR–based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem. 2014;60(9):1183–1191. doi:10.1373/clinchem.2013.221044.
   PubMed Web of Science ®Google Scholar
• Avram L, Iancu SD, Stefancu A, Moisoiu V, Colnita A, Marconi D, et al. SERS-based liquid biopsy of gastrointestinal tumors using a portable Raman device operating in a clinical environment. J Clin Med. 2020;9(1):212. doi:10.3390/jcm9010212.
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Kim DH, Pooler BD, Hinshaw JL, Barlow D, Jensen D, et al. Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history. Lancet Oncol. 2013;14(8):711–720. doi:10.1016/S1470-2045(13)70216-X.
   PubMed Web of Science ®Google Scholar
• Teixeira Y, Lima JM, Souza M, Aguiar P, Silva TD, Forones NM. Human DNA quantification in the stools of patients with colorectal cancer. Arq Gastroenterol. 2015;52(4):293–298. doi:10.1590/S0004-28032015000400008.
   PubMedGoogle Scholar
• Uppara M, Adaba F, Askari A, Clark S, Hanna G, Athanasiou T, Faiz O. A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer. World J Surg Oncol. 2015;13(1):48. doi:10.1186/s12957-015-0446-4.
   PubMedGoogle Scholar
• Bosch LJ, De Wit M, Pham TV, Coupé VM, Hiemstra AC, Piersma SR, et al. Novel stool-based protein biomarkers for improved colorectal cancer screening: a case–control study. Ann Intern Med. 2017;167(12):855–866. doi:10.7326/M17-1068.
   PubMed Web of Science ®Google Scholar
• Evert J, Pathak S, Sun X-F, Zhang H. A study on effect of oxaliplatin in MicroRNA expression in human colon cancer. J Cancer. 2018;9(11):2046–2053. doi:10.7150/jca.24474.
   PubMed Web of Science ®Google Scholar
• Meng W-J, Pathak S, Zhang X, Adell G, Jarlsfelt I, Holmlund B, et al. Expressions of mir-302a, mir-105, and mir-888 play critical roles in pathogenesis, radiotherapy, and prognosis on rectal cancer patients: A study from rectal cancer patients in a Swedish rectal cancer trial of preoperative radiotherapy to big database analyses. Front Oncol. 2020;10:567042. doi:10.3389/fonc.2020.567042.
   PubMed Web of Science ®Google Scholar
• Sarshar M, Scribano D, Ambrosi C, Palamara AT, Masotti A. Fecal microRNAs as innovative biomarkers of intestinal diseases and effective players in host-microbiome interactions. Cancers. 2020;12(8):2174. doi:10.3390/cancers12082174.
   PubMed Web of Science ®Google Scholar
• Davila RE, Rajan E, Baron TH, Adler DG, Egan JV, Faigel DO, et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc. 2006;63(4):546–557. doi:10.1016/j.gie.2006.02.002.
   PubMed Web of Science ®Google Scholar
• Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99(19):1462–1470. doi:10.1093/jnci/djm150.
   PubMedGoogle Scholar
• Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer. 2013;49(14):3049–3054. doi:10.1016/j.ejca.2013.04.023.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Gruber RN, Stump TE, Emmett TW, Monahan PO. Performance characteristics of fecal immunochemical tests for colorectal cancer and advanced adenomatous polyps: a systematic review and meta-analysis. Ann Intern Med. 2019;170(5):319–329. doi:10.7326/M18-2390.
   PubMed Web of Science ®Google Scholar
• Niedermaier T, Balavarca Y, Brenner H. Stage-specific sensitivity of fecal immunochemical tests for detecting colorectal cancer: systematic review and meta-analysis. Am J Gastroenterol. 2020;115(1):56–69. doi:10.14309/ajg.0000000000000465.
   PubMed Web of Science ®Google Scholar
• Zanutto S, Ciniselli CM, Belfiore A, Lecchi M, Masci E, Delconte G, et al. Plasma miRNA‐based signatures in CRC screening programs. Int J Cancer. 2020;146(4):1164–1173. doi:10.1002/ijc.32573.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(9):525–532. doi:10.1056/NEJM198809013190901.
   PubMed Web of Science ®Google Scholar
• Dickinson BT, Kisiel J, Ahlquist DA, Grady WM. Molecular markers for colorectal cancer screening. Gut. 2015;64(9):1485–1494. doi:10.1136/gutjnl-2014-308075.
   PubMed Web of Science ®Google Scholar
• D'Andrea E, Ahnen DJ, Sussman DA, Najafzadeh M. Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality. Cancer Med. 2020;9(2):824–836. doi:10.1002/cam4.2735.
   PubMed Web of Science ®Google Scholar
• Momparler RL. Cancer epigenetics. Oncogene. 2003;22(42):6479–6483. doi:10.1038/sj.onc.1206774.
   PubMed Web of Science ®Google Scholar
• Lamb YN, Dhillon S. Epi proColon® 2.0 CE: a blood-based screening test for colorectal cancer. Mol Diagn Ther. 2017;21(2):225–232. doi:10.1007/s40291-017-0259-y.
   PubMed Web of Science ®Google Scholar
• Johnson DA, Barclay RL, Mergener K, Weiss G, König T, Beck J, Potter NT. Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study. PLOS One. 2014;9(6):e98238. doi:10.1371/journal.pone.0098238.
   PubMed Web of Science ®Google Scholar
• Tóth K, Sipos F, Kalmár A, Patai AV, Wichmann B, Stoehr R, et al. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PLOS One. 2012;7(9):e46000. doi:10.1371/journal.pone.0046000[PMC].
   PubMed Web of Science ®Google Scholar
• Weiss G, Rösch T. Potential of a new blood test for colorectal cancer screening–the septin 9 gene biomarker. Eur Oncol. 2010;06(01):51–54. doi:10.17925/EOH.2010.06.1.51.
   Google Scholar
• Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2014;63(2):317–325. doi:10.1136/gutjnl-2012-304149.
   PubMed Web of Science ®Google Scholar
• Hariharan R, Jenkins M. Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy. BMJ Open Gastroenterol. 2020;7(1):e000355. doi:10.1136/bmjgast-2019-000355.
   PubMed Web of Science ®Google Scholar
• Nian J, Sun X, Ming S, Yan C, Ma Y, Feng Y, et al. Diagnostic accuracy of methylated SEPT9 for blood-based colorectal cancer detection: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2017;8(1):e216. doi:10.1038/ctg.2016.66.
   PubMed Web of Science ®Google Scholar
• Brozek-Pluska B, Musial J, Kordek R, Abramczyk H. Analysis of human colon by Raman spectroscopy and imaging-elucidation of biochemical changes in carcinogenesis. Int J Mol Sci. 2019;20(14):3398. doi:10.3390/ijms20143398.
   PubMed Web of Science ®Google Scholar
• Noothalapati H, Iwasaki K, Yamamoto T. Non-invasive diagnosis of colorectal cancer by Raman spectroscopy: Recent developments in liquid biopsy and endoscopy approaches. Spectrochim Acta A Mol Biomol Spectrosc. 2021;258:119818. doi:10.1016/j.saa.2021.119818.
   PubMed Web of Science ®Google Scholar
• McGregor HC, Short MA, Lam S, Shaipanich T, Beaudoin EL, Zeng H. Development and in vivo test of a miniature Raman probe for early cancer detection in the peripheral lung. J Biophotonics. 2018;11(11):e201800055. doi:10.1002/jbio.201800055.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Kang W, Chen C, Shi X, Yang Y, Yu C. Diagnosis accuracy of Raman spectroscopy in colorectal cancer: A PRISMA-compliant systematic review and meta-analysis. Medicine. 2019;98(34):e16940. doi:10.1097/MD.0000000000016940.
   PubMed Web of Science ®Google Scholar
• Ito H, Uragami N, Miyazaki T, Yang W, Issha K, Matsuo K, et al. Highly accurate colorectal cancer prediction model based on Raman spectroscopy using patient serum. World J Gastrointest Oncol. 2020;12(11):1311–1324. doi:10.4251/wjgo.v12.i11.1311.
   PubMed Web of Science ®Google Scholar
• Tie Y. 200P Diagnostic accuracy of Raman spectroscopy for malignant and benign colorectal lesions: A meta-analysis. Ann. Oncol. 2016;27:ix62. doi:10.1016/S0923-7534(21)00358-6.
   Web of Science ®Google Scholar
• Feng S, Wang W, Tai IT, Chen G, Chen R, Zeng H. Label-free surface-enhanced Raman spectroscopy for detection of colorectal cancer and precursor lesions using blood plasma. Biomed Opt Express. 2015;6(9):3494–3502. doi:10.1364/BOE.6.003494.
   PubMed Web of Science ®Google Scholar
• Wang J, Lin D, Lin J, Yu Y, Huang Z, Chen Y, et al. Label-free detection of serum proteins using surface-enhanced Raman spectroscopy for colorectal cancer screening. J Biomed Opt. 2014;19(8):087003. doi:10.1117/1.JBO.19.8.087003.
   PubMed Web of Science ®Google Scholar
• Li X, Yang T, Li CS, Song Y, Lou H, Guan D, Jin L. Surface enhanced Raman spectroscopy (SERS) for the multiplex detection of Braf, Kras, and Pik3ca mutations in plasma of colorectal cancer patients. Theranostics. 2018;8(6):1678–1689. doi:10.7150/thno.22502.
   PubMed Web of Science ®Google Scholar
• Kita Y, Yonemori K, Osako Y, Baba K, Mori S, Maemura K, Natsugoe S. Noncoding RNA and colorectal cancer: its epigenetic role. J Hum Genet. 2017;62(1):41–47. doi:10.1038/jhg.2016.66.
   PubMed Web of Science ®Google Scholar
• Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nat Rev Genet. 2009;10(2):94–108. doi:10.1038/nrg2504.
   PubMed Web of Science ®Google Scholar
• Iyer DN, Wan TM-H, Man JH-W, Sin RW-Y, Li X, Lo OS-H, et al. Small RNA profiling of piRNAs in colorectal cancer identifies consistent overexpression of piR-24000 that correlates clinically with an aggressive disease phenotype. Cancers. 2020;12(1):188. doi:10.3390/cancers12010188.
   PubMed Web of Science ®Google Scholar
• Weng W, Liu N, Toiyama Y, Kusunoki M, Nagasaka T, Fujiwara T, et al. Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer. Mol Cancer. 2018;17(1):16. doi:10.1186/s12943-018-0767-3.
   PubMed Web of Science ®Google Scholar
• Mai D, Ding P, Tan L, Zhang J, Pan Z, Bai R, et al. PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinoma. Theranostics. 2018;8(19):5213–5230. doi:10.7150/thno.28001.
   PubMed Web of Science ®Google Scholar
• Mai D, Zheng Y, Guo H, Ding P, Bai R, Li M, et al. Serum piRNA-54265 is a new biomarker for early detection and clinical surveillance of human colorectal cancer. Theranostics. 2020;10(19):8468–8478. doi:10.7150/thno.46241.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang H, Ma D, Mu Y, Tan X, Hao Q, et al. Serum PIWI-interacting RNAs piR-020619 and piR-020450 are promising novel biomarkers for early detection of colorectal CancerCRC-specific noninvasive early detection biomarkers. Cancer Epidemiol Biomarkers Prev. 2020;29(5):990–998. doi:10.1158/1055-9965.EPI-19-1148.
   PubMed Web of Science ®Google Scholar
• Feng J, Yang M, Wei Q, Song F, Zhang Y, Wang X, et al. Novel evidence for oncogenic piRNA‐823 as a promising prognostic biomarker and a potential therapeutic target in colorectal cancer. J Cell Mol Med. 2020;24(16):9028–9040. doi:10.1111/jcmm.15537.
   PubMed Web of Science ®Google Scholar
• Sabbah NA, Abdalla WM, Mawla WA, AbdAlMonem N, Gharib AF, Abdul-Saboor A, et al. PiRNA-823 is a unique potential diagnostic non-invasive biomarker in colorectal cancer patients. Genes. 2021;12(4):598. doi:10.3390/genes12040598.
   PubMed Web of Science ®Google Scholar
• Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15(6):321–333. doi:10.1038/nrc3932.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513–10518. doi:10.1073/pnas.0804549105.
   PubMed Web of Science ®Google Scholar
• Ganesan H, Nandy SK, Banerjee A, Pathak S, Zhang H, Sun X-F. RNA-interference-mediated miR-122-based gene regulation in colon cancer, a structural in silico analysis. Int J Mol Sci. 2022;23(23):15257. doi:10.3390/ijms232315257.
   PubMed Web of Science ®Google Scholar
• Krishnan M, Babu S, Jayaraman S, Daniel P, Solomon A, Chinnaiyan M. Microrna-31 as a potential therapeutic biomarker for oral squamous cell carcinoma: current evidence and future prospects. Exp Oncol. 2022;44(3):263–264. doi:10.32471/exp-oncology.2312-8852.vol-44-no-3.18569.
   PubMedGoogle Scholar
• Babu S, Krishnan M, Veeraraghavan VP, Jayaraman S. Role of salivary miRNAs in the diagnosis and prognosis of head and neck squamous cell carcinoma. Oral Oncol. 2022;132:105993. doi:10.1016/j.oraloncology.2022.105993.
   PubMed Web of Science ®Google Scholar
• Jothimani G, Sriramulu S, Chabria Y, Sun X-F, Banerjee A, Pathak S. A review on theragnostic applications of microRNAs and long non-coding RNAs in colorectal cancer. Curr Top Med Chem. 2018;18(30):2614–2629. doi:10.2174/1568026619666181221165344.
   PubMed Web of Science ®Google Scholar
• Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg. 2014;259(4):735–743. doi:10.1097/SLA.0b013e3182a6909d.
   PubMed Web of Science ®Google Scholar
• Malayaperumal S, Sriramulu S, Banerjee A, Pathak S. Over-expression of MicroRNA-122 inhibits proliferation and induces apoptosis in colon cancer cells. Microrna. 2020;9(5):354–362. doi:10.2174/2211536609666201209152228.
   PubMedGoogle Scholar
• Maierthaler M, Benner A, Hoffmeister M, Surowy H, Jansen L, Knebel P, et al. Plasma miR‐122 and miR‐200 family are prognostic markers in colorectal cancer. Int J Cancer. 2017;140(1):176–187. doi:10.1002/ijc.30433.
   PubMed Web of Science ®Google Scholar
• Elaguizy M, Sheta M, Ibrahim N, Eltaweel A, Mostafa A. Serum microRNA-18a, microRNA-21 and microRNA-92a as diagnostic markers in colorectal cancer patients. J Buon. 2020;25(3):1443–1448. PMID: 32862588
   PubMed Web of Science ®Google Scholar
• Jin X-H, Lu S, Wang A-F. Expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer. BMC Cancer. 2020;20(1):241. doi:10.1186/s12885-020-06715-6.
   PubMed Web of Science ®Google Scholar
• Pan C, Yan X, Li H, Huang L, Yin M, Yang Y, et al. Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancer. Oncotarget. 2017;8(40):68317–68328. doi:10.18632/oncotarget.19344.
   PubMedGoogle Scholar
• Soung YH, Ford S, Zhang V, Chung J. Exosomes in cancer diagnostics. Cancers (Basel). 2017;9(1):8. doi:10.3390/cancers9010008.
   PubMed Web of Science ®Google Scholar
• Han L, Shi WJ, Xie YB, Zhang ZG. Diagnostic value of four serum exosome microRNAs panel for the detection of colorectal cancer. World J Gastrointest Oncol. 2021;13(8):970–979. doi:10.4251/wjgo.v13.i8.970.
   PubMed Web of Science ®Google Scholar
• Liu X, Pan B, Sun L, Chen X, Zeng K, Hu X, et al. Circulating exosomal miR-27a and miR-130a act as novel diagnostic and prognostic biomarkers of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(7):746–754. doi:10.1158/1055-9965.EPI-18-0067.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhuang Y, Zhang J, Chen M, Wu S. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer. Tissue Cell. 2021;70:101499. doi:10.1016/j.tice.2021.101499.
   PubMed Web of Science ®Google Scholar
• Baeßler B, Maintz D, Persigehl T. Imaging procedures for colorectal cancer. Visc Med. 2016;32(3):166–171. doi:10.1159/000446143.
   PubMed Web of Science ®Google Scholar
• Brown G, Radcliffe A, Newcombe R, Dallimore N, Bourne M, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90(3):355–364. doi:10.1002/bjs.4034.
   PubMed Web of Science ®Google Scholar
• Ganeshan D, Elsayes KM, Vining D. Virtual colonoscopy: utility, impact and overview. World J Radiol. 2013;5(3):61–67. doi:10.4329/wjr.v5.i3.61.
   PubMedGoogle Scholar
• Laghi A. Computed tomography colonography in 2014: an update on technique and indications. World J Gastroenterol. 2014;20(45):16858–16867. doi:10.3748/wjg.v20.i45.16858.
   PubMed Web of Science ®Google Scholar
• Lin OS-T. Computed tomographic colonography: hope or hype? World J Gastroenterol. 2010;16(8):915–920. doi:10.3748/wjg.v16.i8.915.
   PubMed Web of Science ®Google Scholar
• Van Gelder RE, Nio CY, Florie J, Bartelsman JF, Snel P, De Jager SW, et al. Computed tomographic colonography compared with colonoscopy in patients at increased risk for colorectal cancer. Gastroenterology. 2004;127(1):41–48. doi:10.1053/j.gastro.2004.03.055.
   PubMed Web of Science ®Google Scholar
• Regge D, Laudi C, Galatola G, Della Monica P, Bonelli L, Angelelli G, et al. Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer. JAMA. 2009;301(23):2453–2461. doi:10.1001/jama.2009.832.
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection—systematic review and meta-analysis. Radiology. 2011;259(2):393–405. doi:10.1148/radiol.11101887.
   PubMed Web of Science ®Google Scholar
• Hoshino N, Sakamoto T, Hida K, Sakai Y. Diagnostic accuracy of computed tomography colonography for tumor depth in colorectal cancer: a systematic review and meta-analysis. Surg Oncol. 2019;30:126–130. doi:10.1016/j.suronc.2019.08.003.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Han Z, Dou F, Yan T. Pre-colectomy location and TNM staging of colon cancer by the computed tomography colonography: a diagnostic performance study. World J Surg Oncol. 2021;19(1):120. doi:10.1186/s12957-021-02215-4.
   PubMed Web of Science ®Google Scholar
• Young BM, Fletcher JG, Earnest F, Fidler JL, MacCarty RL, Johnson CD, et al. Colonic perforation at CT colonography in a patient without known colonic disease. AJR Am J Roentgenol. 2006;186(1):119–121. doi:10.2214/AJR.04.1649.
   PubMed Web of Science ®Google Scholar
• Morrin MM, Kruskal JB, Farrell RJ, Goldberg SN, McGee JB, Raptopoulos V. Endoluminal CT colonography after an incomplete endoscopic colonoscopy. AJR Am J Roentgenol. 1999;172(4):913–918. doi:10.2214/ajr.172.4.10587120.
   PubMed Web of Science ®Google Scholar
• Spada C, Hassan C, Bellini D, Burling D, Cappello G, Carretero C, et al. Imaging alternatives to colonoscopy: CT colonography and colon capsule. European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) guideline–update 2020. Endoscopy. 2020;52(12):1127–1141. doi:10.1055/a-1258-4819.
   PubMed Web of Science ®Google Scholar
• Zerhouni EA, Rutter C, Hamilton SR, Balfe DM, Megibow AJ, Francis IR, et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology. Radiology. 1996;200(2):443–451. doi:10.1148/radiology.200.2.8685340.
   PubMed Web of Science ®Google Scholar
• Chung DJ, Huh KC, Choi WJ, Kim JK. CT colonography using 16-MDCT in the evaluation of colorectal cancer. AJR Am J Roentgenol. 2005;184(1):98–103. doi:10.2214/AJR.15.15785.
   PubMed Web of Science ®Google Scholar
• Narayanan S, Kalra N, Bhatia A, Wig J, Rana S, Bhasin D, et al. Staging of colorectal cancer using contrast-enhanced multidetector computed tomographic colonography. Singapore Med J. 2014;55(12):660–666. doi:10.11622/smedj.2014182.
   PubMed Web of Science ®Google Scholar
• Tezcan D, Türkvatan A, Türkoğlu MA, Bostancı EB, Sakaoğullları Z. Preoperative staging of colorectal cancer: accuracy of single portal venous phase multidetector computed tomography. Clin Imaging. 2013;37(6):1048–1053. doi:10.1016/j.clinimag.2013.08.003.
   PubMed Web of Science ®Google Scholar
• Vliegen R, Dresen R, Beets G, Daniels-Gooszen A, Kessels A, van Engelshoven J, Beets-Tan R. The accuracy of Multi-detector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancer. Abdom Imaging. 2008;33(5):604–610. doi:10.1007/s00261-007-9341-y.
   PubMedGoogle Scholar
• Raman SP, Chen Y, Fishman EK. Evolution of imaging in rectal cancer: multimodality imaging with MDCT, MRI, and PET. J Gastrointest Oncol. 2015;6(2):172–184. doi:10.3978/j.issn.2078-6891.2014.108.
   PubMedGoogle Scholar
• Schoofs N, Devière J, Van Gossum A. PillCam colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy. 2006;38(10):971–977. doi:10.1055/s-2006-944835.
   PubMed Web of Science ®Google Scholar
• Eliakim R, Yassin K, Niv Y, Metzger Y, Lachter J, Gal E, et al. Prospective multicenter performance evaluation of the second-generation colon capsule compared with colonoscopy. Endoscopy. 2009;41(12):1026–1031. doi:10.1055/s-0029-1215360.
   PubMed Web of Science ®Google Scholar
• Spada C, Hassan C, Galmiche J-P, Neuhaus H, Dumonceau J-M, Adler S, et al. Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2012;44(5):527–536. doi:10.1055/s-0031-1291717.
   PubMed Web of Science ®Google Scholar
• Parodi A, Vanbiervliet G, Hassan C, Hebuterne X, De Ceglie A, Filiberti RA, et al. Colon capsule endoscopy to screen for colorectal neoplasia in those with family histories of colorectal cancer. Gastrointest Endosc. 2018;87(3):695–704. doi:10.1016/j.gie.2017.05.023.
   PubMed Web of Science ®Google Scholar
• Vuik FE, Nieuwenburg SA, Moen S, Spada C, Senore C, Hassan C, et al. Colon capsule endoscopy in colorectal cancer screening: a systematic review. Endoscopy. 2021;53(8):815–824. doi:10.1055/a-1342-1343.
   PubMed Web of Science ®Google Scholar
• Möllers T, Schwab M, Gildein L, Hoffmeister M, Albert J, Brenner H, Jäger S. Second-generation colon capsule endoscopy for detection of colorectal polyps: systematic review and meta-analysis of clinical trials. Endosc Int Open. 2021;9(4):E562–E571. doi:10.1055/a-1353-4849.
   PubMedGoogle Scholar
• Kjølhede T, Ølholm AM, Kaalby L, Kidholm K, Qvist N, Baatrup G. Diagnostic accuracy of capsule endoscopy compared with colonoscopy for polyp detection: systematic review and meta-analyses. Endoscopy. 2021;53(7):713–721. doi:10.1055/a-1282-3817.
   PubMedGoogle Scholar
• Shirin H, Shpak B, Epshtein J, Karstensen JG, Hoffman A, de Ridder R, et al. G-EYE colonoscopy is superior to standard colonoscopy for increasing adenoma detection rate: an international randomized controlled trial (with videos). Gastrointest Endosc. 2019;89(3):545–553. doi:10.1016/j.gie.2018.09.028.
   PubMed Web of Science ®Google Scholar
• Kiesslich R, Teubner D, Hoffman A, Rey JW. Retrospective comparison of G-EYE balloon-colonoscopy with standard colonoscopy for increased adenoma detection rate and reduced polyp removal time. Endosc Int Open. 2023;11(9):E920–E927. doi:10.1055/a-2005-6934.
   PubMedGoogle Scholar
• Ryu JY, Park BK, Kim W-S, Kim K, Lee JY, Kim Y, et al. Endoscopic closure of iatrogenic colon perforation using dual-channel endoscope with an endoloop and clips: methods and feasibility data (with videos). Surg Endosc. 2019;33(4):1342–1348. doi:10.1007/s00464-018-06616-7.
   PubMed Web of Science ®Google Scholar
• Friedland S, Pan JY, Watson D, Chen Y, Nimgaonkar A, Gulzar Z, et al. A sensitive and quantitative multimodal blood test for the detection of colorectal adenomas and cancer: Correlation with size and number of polyps. JCO. 2020;38(15 suppl):1555–1555. doi:10.1200/JCO.2020.38.15_suppl.1555.
   Web of Science ®Google Scholar
• Friedland S, Pan JY, Watson D, Chen Y, Nimgaonkar A, Gulzar Z, et al. Development and clinical validation of a blood test for early detection of colorectal adenomas and cancer. JCO. 2021;39(3_suppl):50–50. doi:10.1200/JCO.2021.39.3_suppl.50.
   Web of Science ®Google Scholar
• Bessa X, Balboa JC, Márquez C, Duenwald S, He Y, Raymond V, et al. High accuracy of a blood ctDNA-based multimodal test to detect colorectal cancer. Ann Oncol. 2023;34(12):1187–1193. Oct 5. doi:10.1016/j.annonc.2023.09.3113.
   PubMed Web of Science ®Google Scholar
• Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188–196. doi:10.1016/j.ejphar.2018.07.034.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang Q, Xu J, Tang L, Zhang Y, Du F, et al. PROTACs in gastrointestinal cancers. Mol Ther Oncolytics. 2022;27:204–223.
   PubMed Web of Science ®Google Scholar
• Tao J, Tu Y, Liu P, Tang Y, Wang F, Li Z, et al. Detection of colorectal cancer using a small molecular fluorescent probe targeted against c-Met. Talanta. 2021;226:122128. doi:10.1016/j.talanta.2021.122128.
   PubMed Web of Science ®Google Scholar
• Lwin TM, Turner MA, Amirfakhri S, Nishino H, Hoffman RM, Bouvet M. Fluorescence molecular targeting of colon cancer to visualize the invisible. Cells. 2022;11(2):249. doi:10.3390/cells11020249.
   PubMed Web of Science ®Google Scholar
• Maeda H. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J Control Release. 2012;164(2):138–144. doi:10.1016/j.jconrel.2012.04.038.
   PubMed Web of Science ®Google Scholar
• Galema HA, Meijer RP, Lauwerends LJ, Verhoef C, Burggraaf J, Vahrmeijer AL, et al. Fluorescence-guided surgery in colorectal cancer; a review on clinical results and future perspectives. Eur J Surg Oncol. 2022;48(4):810–821. doi:10.1016/j.ejso.2021.10.005.
   PubMed Web of Science ®Google Scholar
• Bailey JR, Aggarwal A, Imperiale TF. Colorectal cancer screening: stool DNA and other noninvasive modalities. Gut Liver. 2016;10(2):204–211. doi:10.5009/gnl15420.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang H, Fan C, Hildesjö C, Shen B, Sun X-F. Loss of CHGA protein as a potential biomarker for colon cancer diagnosis: a study on biomarker discovery by machine learning and confirmation by immunohistochemistry in colorectal cancer tissue microarrays. Cancers (Basel). 2022;14(11):2664. doi:10.3390/cancers14112664.
   PubMed Web of Science ®Google Scholar
• Li D. Recent advances in colorectal cancer screening. Chronic Dis Transl Med. 2018;4(3):139–147. doi:10.1016/j.cdtm.2018.08.004.
   PubMedGoogle Scholar
• Rabeneck L, Rumble RB, Thompson F, Mills M, Oleschuk C, Whibley A, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol. 2012;26(3):131–147. doi:10.1155/2012/486328.
   PubMed Web of Science ®Google Scholar
• Rozen P, Knaani J, Samuel Z. Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test. Dig Dis Sci. 1999;44(4):756–760. doi:10.1023/a:1026618010312.
   PubMed Web of Science ®Google Scholar
• Sun J, Fei F, Zhang M, Li Y, Zhan X, Zhu S, Zhang S. The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer. BMC Cancer. 2019;19(1):450. doi:10.1186/s12885-019-5663-8.
   PubMedGoogle Scholar
• González-Suárez B, Pagés M, Araujo IK, Romero C, Rodríguez de Miguel C, Ayuso JR, et al. Colon capsule endoscopy versus CT colonography in FIT-positive colorectal cancer screening subjects: a prospective randomised trial—the VICOCA study. BMC Med. 2020;18(1):255. doi:10.1186/s12916-020-01717-4.
   PubMed Web of Science ®Google Scholar